According to a report by Reports and Data, the global Biosimulation Market size was USD 2.78 billion in 2022 and is expected to have a revenue CAGR of 16% during the forecast period. Biosimulation is becoming more popular in drug development as it can predict the safety and efficacy of a drug candidate, which saves time and money by eliminating the need for clinical trials.
Biosimulation is...
English
العربية
Français
Español
Português
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Português
Ελληνικά